Related Experiment Video

Updated: Sep 12, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

[Current trends in the drug therapy of childhood asthma]

G Mezei1

  • 1I. Gyermekklinika, Semmelweis Orvostudományi Egyetem, Budapest.

Orvosi Hetilap
|August 7, 1999
PubMed

Insights

Effective asthma management involves prophylactic therapy to minimize symptoms and prevent exacerbations. Inhaled corticosteroids are recommended for moderate to severe asthma, with inhaled administration offering the best clinical effect and fewest side effects.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology
  • Respiratory Medicine

Context:

  • Asthma is a chronic respiratory disease affecting children and adults, characterized by airway inflammation and reversible airflow obstruction.
  • Current guidelines emphasize prophylactic therapy to control asthma symptoms and reduce exacerbations.
  • Effective asthma management aims to minimize symptoms, prevent exacerbations, and decrease overall disease morbidity.

Purpose:

  • To review current therapeutic strategies for asthma management, focusing on prophylactic treatments.
  • To evaluate the efficacy and safety of inhaled corticosteroids and kromones in pediatric asthma.
  • To highlight the importance of inhaled drug delivery for optimal asthma treatment outcomes.

Summary:

  • Asthma treatment goals include symptom reduction, exacerbation prevention, and decreased morbidity.
  • Therapeutic strategies involve suppressing inflammation using kromones for mild childhood asthma or inhaled corticosteroids for moderate to severe cases.
  • Inhaled corticosteroids offer benefits that outweigh potential growth impairment, with inhaled administration providing maximal clinical effect and minimal systemic side effects.
  • Age is a critical factor in determining appropriate inhaled therapy, with drug delivery posing challenges in infants and toddlers.

Impact:

  • Provides an overview of current asthma treatment guidelines and therapeutic options.
  • Emphasizes the advantages of inhaled corticosteroid therapy in pediatric asthma.
  • Identifies challenges in drug delivery for young children, suggesting areas for future research and development.

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: